Status: Recruiting
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC). In addition, the study will evaluate the potential of OD-07656 to enhance the therapeutic benefit of vedolizumab when given after OD-07656.
Participants needed: 57
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Odyssey TherapeuticsUpdated: Feb 11, 2026Locations: 32
Eligibility criteria
Has a confirmed diagnosis of ulcerative colitis (UC) [+2]
Has diagnosis of Crohn's disease or indeterminate colitis [+3]